Browsing: Treatment

HealthDay News — Adolescents and young adults are increasingly using glucagon-like peptide-1 receptor agonist (GLP-1 RA) weight-loss drugs for obesity care, according to a research letter published online July 20 in JAMA Pediatrics

SA study finds doravirine works as well as dolutegravir to suppress HIV viral load, enabling choice for those living with HIV

JACKSONVILLE, Fla. – It’s a rare but potentially serious disease that affects thousands of Americans every year

The World Health Organization (WHO) has issued major updates to its leishmaniasis treatment guidelines for eastern Africa and South-East Asia, recommending new regimens that significantly improve patient care. The new WHO guidelines, released today, are applicable for visceral leishmaniasis (VL, also called kala-azar), a deadly disease, and for post-kala-azar dermal leishmaniasis (PKDL)

detail *It has been translated using AI Eli Lilly’s obesity treatment “Munzaro” surpassed its rival product “Wigobi” in the cumulative number of prescriptions 10 months after it was released in Korea. Competition for high-dose products and next-generation new drugs is also in full swing as it quickly dominates the market with excellent weight loss effects.…

Childhood obesity affects one in five children in the U.S., yet most families have limited access to specialized weight-management programs for children. Now, a large clinical trial led by researchers at Washington University School of Medicine in St. Louis, the University of Rochester Medical Center, the LSU Pennington Biomedical Research Center and the American Academy…

The 29‑year‑old Olympian told fans on Thursday she was receiving medical treatment in what appears to be a clinical setting just weeks after saying she “almost died” during a health scare

Hernando Salcedo was surprised when he noticed his stomach swelling in May 2025. The 83-year-old grandfather had always been healthy and active. He’d had some hip pain recently, but thought it was his age. The swelling came out of nowhere and didn’t have a clear cause. 

Cerebral small vessel disease (CSVD), which notably increases the risk of stroke and cognitive disorders, is estimated to affect more than 5 million people in France alone. In the absence of a curative treatment, the prevention of cardiovascular risk factors remains the most effective strategy today. However, promising new therapeutic avenues are being explored

Early psychosis is disruptive and frightening—not only for the person experiencing it, but also for family members and friends trying to understand what is happening and find appropriate care. Javier Ortiz Orendain, MD, describes psychosis as a “breakdown in shared understanding of reality,” in which a person may experience hallucinations – perceiving things others do…